These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27083254)

  • 1. Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography-tandem mass spectrometry.
    Swortwood MJ; Scheidweiler KB; Barnes AJ; Jansson LM; Huestis MA
    J Chromatogr A; 2016 May; 1446():70-7. PubMed ID: 27083254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of buprenorphine, naloxone and their metabolites in rat plasma using hydrophilic interaction liquid chromatography coupled with tandem mass spectrometry.
    Joshi A; Parris B; Liu Y; Heidbreder C; Gerk PM; Halquist M
    Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27390058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of buprenorphine, norbuprenorphine, naloxone, and their glucuronides in urine by liquid chromatography-tandem mass spectrometry.
    Mariottini C; Gergov M; Ojanperä I
    Drug Test Anal; 2021 Sep; 13(9):1658-1667. PubMed ID: 34047070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry.
    Concheiro M; Shakleya DM; Huestis MA
    Forensic Sci Int; 2009 Jul; 188(1-3):144-51. PubMed ID: 19406593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UHPLC-MS/MS quantification of buprenorphine, norbuprenorphine, methadone, and glucuronide conjugates in umbilical cord plasma.
    Kyle AR; Carmical J; Shah D; Pryor J; Brown S
    Biomed Chromatogr; 2015 Oct; 29(10):1567-74. PubMed ID: 25808363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation and application of a method for the determination of buprenorphine, norbuprenorphine, and their glucuronide conjugates in human meconium.
    Kacinko SL; Shakleya DM; Huestis MA
    Anal Chem; 2008 Jan; 80(1):246-52. PubMed ID: 18044957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Huang W; Moody DE; McCance-Katz EF
    Ther Drug Monit; 2006 Apr; 28(2):245-51. PubMed ID: 16628138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified processing and rapid quantification of buprenorphine, norbuprenorphine, and their conjugated metabolites in human plasma using UPLC-MS/MS: Assessment of buprenorphine exposure during opioid use disorder treatment.
    Zhao W; Alshogran OY; Zhang H; Joshi A; Krans EE; Caritis S; Shaik IH; Venkataramanan R
    J Mass Spectrom; 2024 Apr; 59(4):e5015. PubMed ID: 38501738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of buprenorphine, norbuprenorphine and naloxone in human plasma by liquid chromatography/tandem mass spectrometry.
    Liu Y; Li X; Xu A; Nasser AF; Heidbreder C
    J Pharm Biomed Anal; 2016 Feb; 120():142-52. PubMed ID: 26730511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of buprenorphine, naloxone and phase I and phase II metabolites in rat whole blood by LC-MS/MS.
    Cohier C; Salle S; Fontova A; Mégarbane B; Roussel O
    J Pharm Biomed Anal; 2020 Feb; 180():113042. PubMed ID: 31865207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of Buprenorphine, Norbuprenorphine, Buprenorphine Glucuronide, Norbuprenorphine Glucuronide, and Naloxone in Urine by LC-MS/MS.
    Marin SJ; McMillin GA
    Methods Mol Biol; 2016; 1383():69-78. PubMed ID: 26660175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.
    Concheiro M; Jones H; Johnson RE; Shakleya DM; Huestis MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):13-20. PubMed ID: 19945361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography-mass spectrometry.
    Regina KJ; Kharasch ED
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():23-31. PubMed ID: 24095872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of buprenorphine, norbuprenorphine, and metabolites in human urine.
    Kacinko SL; Concheiro-Guisan M; Shakleya DM; Huestis MA
    Anal Bioanal Chem; 2008 Nov; 392(5):903-11. PubMed ID: 18758763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies.
    Moody DE; Slawson MH; Strain EC; Laycock JD; Spanbauer AC; Foltz RL
    Anal Biochem; 2002 Jul; 306(1):31-9. PubMed ID: 12069411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry.
    Concheiro M; Gray TR; Shakleya DM; Huestis MA
    Anal Bioanal Chem; 2010 Sep; 398(2):915-24. PubMed ID: 20652688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of buprenorphine, norbuprenorphine and naloxone in fingernail clippings and urine of patients under opioid substitution therapy.
    Tzatzarakis MN; Vakonaki E; Kovatsi L; Belivanis S; Mantsi M; Alegakis A; Liesivuori J; Tsatsakis AM
    J Anal Toxicol; 2015 May; 39(4):313-20. PubMed ID: 25663675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatographic/electrospray ionization tandem mass spectrometric analysis for the quantification of buprenorphine, norbuprenorphine, buprenorphine-3-beta-D-glucuronide and norbuprenorphine-3-beta-D-glucuronide in human plasma.
    Murphy CM; Huestis MA
    J Mass Spectrom; 2005 Jan; 40(1):70-4. PubMed ID: 15637731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hollow fiber liquid-phase microextraction combined with ultra-high performance liquid chromatography-tandem mass spectrometry for the simultaneous determination of naloxone, buprenorphine and norbuprenorphine in human plasma.
    Sun W; Qu S; Du Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 951-952():157-63. PubMed ID: 24566267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of free (unconjugated) buprenorphine, norbuprenorphine, and their glucuronides in urine using liquid chromatography-tandem mass spectrometry.
    McMillin GA; Davis R; Carlisle H; Clark C; Marin SJ; Moody DE
    J Anal Toxicol; 2012 Mar; 36(2):81-7. PubMed ID: 22337776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.